Regression of mouse-derived renal cancer by adoptive transfer of tumor-reactive RNAi-induced TGF-beta-insensitive CD8+ T cells

  • Bin Song
  • Wei-jun Qin
  • Zeng-yue Yang
  • Ting-yi Bao
  • Xia Yang
  • Fu-li Wang
  • Geng Zhang
  • An-gang Yang
  • He Wang

Abstract

Transforming growth factor beta (TGF-beta) is a potent immunosuppressant. The present study was conducted to develop a treatment strategy through adoptive transfer of tumor-reactive RNAi-induced TGF-beta-insensitive CD8+ T cells. BALB/c mice were primed with irradiated Renca cells. CD8+ T cells were isolated from the spleen of primed animals, expanded ex vivo and were rendered TGF-beta-insensitive by infecting with a retrovirus containing shRNA to mouse TGF-beta type II receptor gene (MSCV-shRNA-T). Control CD8+ T cells consist of those infected with retroviruses containing shRNA to non specific gene (MSCV-shRNA-N) and naive CD8+ T cells. The effect of all groups of CD8+ T cells on Renca cells were analyzed by semi-quantitative RT-PCR, Western-blot, in vitro and in vivo assay. MSCVshRNA-T group of CD8+ T cells were resistant to the antiproliferative effect of exogenous TGF-beta, while control groups were not. Results of Western blot showed the Smad pathway was disrupted in MSCV-shRNA-T group, which confirmed the blockade of the signal transduction pathway. In vitro cytotoxic assay revealed that these tumor-reactive, TGF-beta-insensitive CD8+ T cells killed Renca cells specifically and strongly. Adoptive transfer of these MSCV-shRNA-T CD8+ T cells to BALB/c tumorbearing mice showed strong tumor-specific cytotoxic T lymphocyte responses and antitumor immunity against Renca renal cancer. Based on these results, we predict that adoptive transfer of tumor-reactive RNAi-induced TGF-beta-insensitive CD8+ T cells may be effective to renal cancer therapy.

Keywords: Transforming growth factor beta, adoptive transfer, RNA interference, renal cancer, renca cells, immunotherapy

African Journal of Biotechnology Vol. 9(33), pp. 5274-5283, 16 August, 2010

Author Biographies

Bin Song
Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xin Si Road, Xi'an, 710038, China
Wei-jun Qin
Department of Urology, Xijing Hospital, Fourth Military Medical University, Chang Le West Road 15, Xi'an, 710032, China
Zeng-yue Yang
Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xin Si Road, Xi'an, 710038, China
Ting-yi Bao
Department of Urology, Tangdu Hospital, Fourth Military Medical University, Xin Si Road, Xi'an, 710038, China
Xia Yang
Department of Division of Medical Service, Tangdu Hospital, Fourth Military Medical University, Xin Si Road, Xi'an, 710038, China
Fu-li Wang
Department of Urology, Xijing Hospital, Fourth Military Medical University, Chang Le West Road 15, Xi'an, 710032, China
Geng Zhang
Department of Urology, Xijing Hospital, Fourth Military Medical University, Chang Le West Road 15, Xi'an, 710032, China
An-gang Yang
Department of Immunology, Fourth Military Medical University, Chang Le West Road 17, Xi'an, 710032, China
He Wang
Department of Urology, Xijing Hospital, Fourth Military Medical University, Chang Le West Road 15, Xi'an, 710032, China
Published
2013-08-09
Section
Articles

Journal Identifiers


eISSN: 1684-5315